Neo Ivy Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Neo Ivy Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,808	Closed	-$264K	–	657
2021 Q1	$264K	Buy	3,808 +3,613	+1,853%	+$278K	0.29%	126
2020 Q4	$15K	Sell	195 -3,061	-94%	-$229K	0.02%	374
2020 Q3	$243K	Buy	+3,256	New	+$217K	0.25%	162
2019 Q4	–	Sell	-12,121	Closed	-$641K	–	422
2019 Q3	$641K	Buy	12,121 +3,471	+40%	+$195K	0.42%	110
2019 Q2	$507K	Buy	+8,650	New	+$447K	0.29%	158

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neo Ivy Capital Management's ARNA Position: Q2 2021 in Review

Neo Ivy Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 3,808 shares — an estimated $264K sold.

Neo Ivy Capital Management first reported a position in ARNA in Q2 2019 and held it in 5 quarters. The position peaked at $641K in Q3 2019. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

Neo Ivy Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
Neo Ivy Capital Management sold 3,808 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $264K.
Neo Ivy Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 5 quarters.
Neo Ivy Capital Management's Arena Pharmaceuticals Inc position peaked at $641K in Q3 2019.
237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Neo Ivy Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.